Deviation Detection in Clinical Pathways Based on Business Alignment

Table 2

The relationship between activities and transitions of Figure 6.

Transition	Activity	Transition	Activity
t1	Medical history/body temperature/ECG/chest CT/blood sample collection	t19	Symptoms mainly with COVID-19
t2	Exclusion of COVID-19 infection	t20	Stable vital signs
t3	Suspected or confirmed COVID-19 infection complicated with STEMI	t21	Symptoms mainly with STEMI
t4	Onset time of STEMI in emergency patients > 12 h	t22	Onset time of STEMI in COVID-19 patients > 12 h
t5	Onset time of STEMI in emergency patients ≤ 12 h	t23	Onset time of STEMI in COVID-19 patients ≤ 12 h
t6	Emergency patients with contraindications to thrombolysis	t24	Contraindications to thrombolysis (COVID-19)
t7	Emergency patients without contraindications to thrombolysis	t25	No contraindications to thrombolysis (COVID-19)
t8	CCU thrombolysis	t26	Thrombolytic therapy (isolation ward)
t9	No recanalization of thrombolysis in emergency patients	t27	No recanalization of thrombolysis in COVID-19 patients
t10	Assessment of STEMI patient’s benefits and risks	t28	Assessment of STEMI and COVID-19 patient’s benefits and risks
t11	Recanalization of thrombolysis in emergency patients	t29	STEMI patient’s benefits with COVID-19 > risks
t12	STEMI patient’s benefits ≤ risks	t30	Start-up of protection scheme
t13	STEMI patient’s benefits > risks	t31	COVID-19 isolation catheter room for PCI
t14	Isolation catheter room for PCI	t32	STEMI patient’s benefits with COVID-19 ≤ risks
t15	Continuing treatment in CCU	t33	Isolation ward conservative treatment
t16	CCU conservative treatment	t34	Recanalization of thrombolysis in COVID-19 patients
t17	Selective intervention	t35	Continuing treatment in CCU”
t18	Unstable vital signs	t36	Selective intervention after COVID-19 recovery